GR1000059B - Μεθοδος παρασκευης συζυγων ενωσεων ανοσοσφαιρινης. - Google Patents
Μεθοδος παρασκευης συζυγων ενωσεων ανοσοσφαιρινης.Info
- Publication number
- GR1000059B GR1000059B GR880100148A GR880100148A GR1000059B GR 1000059 B GR1000059 B GR 1000059B GR 880100148 A GR880100148 A GR 880100148A GR 880100148 A GR880100148 A GR 880100148A GR 1000059 B GR1000059 B GR 1000059B
- Authority
- GR
- Greece
- Prior art keywords
- preparation
- antibody
- immunoglobulin compounds
- immunoglobulin
- compounds
- Prior art date
Links
- 108060003951 Immunoglobulin Proteins 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 102000018358 immunoglobulin Human genes 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- 108010032595 Antibody Binding Sites Proteins 0.000 abstract 1
- XDXDZDZNSLXDNA-TZNDIEGXSA-N Idarubicin Chemical compound C1[C@H](N)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2C[C@@](O)(C(C)=O)C1 XDXDZDZNSLXDNA-TZNDIEGXSA-N 0.000 abstract 1
- XDXDZDZNSLXDNA-UHFFFAOYSA-N Idarubicin Natural products C1C(N)C(O)C(C)OC1OC1C2=C(O)C(C(=O)C3=CC=CC=C3C3=O)=C3C(O)=C2CC(O)(C(C)=O)C1 XDXDZDZNSLXDNA-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 229960000908 idarubicin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
- A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPI080387 | 1987-03-11 | ||
| AUPI295587 | 1987-07-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GR880100148A GR880100148A (en) | 1989-01-31 |
| GR1000059B true GR1000059B (el) | 1990-06-27 |
Family
ID=25643244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR880100148A GR1000059B (el) | 1987-03-11 | 1988-03-11 | Μεθοδος παρασκευης συζυγων ενωσεων ανοσοσφαιρινης. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US5798097A ( ) |
| JP (1) | JP2736255B2 ( ) |
| KR (1) | KR0130906B1 ( ) |
| CN (1) | CN1045621C ( ) |
| AT (1) | AT395375B ( ) |
| AU (1) | AU622105B2 ( ) |
| BE (1) | BE1001051A4 ( ) |
| CA (1) | CA1329156C ( ) |
| CH (1) | CH678815A5 ( ) |
| CZ (1) | CZ281193B6 ( ) |
| DE (1) | DE3808166C2 ( ) |
| DK (1) | DK173792B1 ( ) |
| ES (1) | ES2006109A6 ( ) |
| FI (1) | FI98706C ( ) |
| FR (1) | FR2612074B1 ( ) |
| GB (1) | GB2203154B ( ) |
| GR (1) | GR1000059B ( ) |
| HU (1) | HU205266B ( ) |
| IE (1) | IE64781B1 ( ) |
| IL (1) | IL85688A0 ( ) |
| IT (1) | IT8819746A0 ( ) |
| MY (1) | MY103231A ( ) |
| NL (1) | NL8800610A ( ) |
| NO (1) | NO178954C ( ) |
| NZ (1) | NZ223834A ( ) |
| PT (1) | PT86960B ( ) |
| RU (1) | RU2106147C1 ( ) |
| SE (1) | SE503402C2 ( ) |
| YU (1) | YU46858B ( ) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6824777B1 (en) * | 1992-10-09 | 2004-11-30 | Licentia Ltd. | Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| DK1119371T3 (da) * | 1998-10-09 | 2011-03-07 | Vegenics Ltd | Flt4 (VEGFR-3) som et mål for tumorbilleddannelse og antitumorterapi |
| EP1343531A2 (en) * | 2000-12-21 | 2003-09-17 | McGILL UNIVERSITY | Conjugates of antibodies and anticancer drugs |
| JP4669984B2 (ja) | 2001-01-19 | 2011-04-13 | ベジェニクス リミテッド | 腫瘍画像化のターゲットとしてのＦ１ｔ４（ＶＥＧＦＲ−３）および抗腫瘍療法 |
| CA2522700A1 (en) * | 2003-04-18 | 2004-11-04 | Cytovia, Inc. | Methods of treating diseases responsive to induction of apoptosis and screening assays |
| GB0511266D0 (en) * | 2005-06-02 | 2005-07-13 | Trust | Chemical compounds |
| US20080108138A1 (en) * | 2006-06-13 | 2008-05-08 | Vermette Patrick | Bioactive compositions and their use in cell patterning |
| CN110251668A (zh) | 2010-11-30 | 2019-09-20 | 霍夫曼-拉罗奇有限公司 | 低亲和力血脑屏障受体抗体及其用途 |
| NZ710658A (en) | 2013-02-18 | 2019-12-20 | Vegenics Pty Ltd | Ligand binding molecules and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT343811B (de) * | 1975-01-22 | 1978-06-26 | Farmaceutici Italia | Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen |
| AT346838B (de) * | 1975-01-22 | 1978-11-27 | Farmaceutici Italia | Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen |
| GB1500421A (en) * | 1975-01-22 | 1978-02-08 | Farmaceutici Italia | Optically active anthracyclinones |
| AT343812B (de) * | 1975-01-22 | 1978-06-26 | Farmaceutici Italia | Verfahren zur herstellung von neuen optisch aktiven daunosaminylderivaten von anthracyclinonen |
| GB1511680A (en) | 1975-11-18 | 1978-05-24 | Farmaceutici Italia | Daunosaminyl anthracyclinones |
| GB1541436A (en) * | 1976-02-02 | 1979-02-28 | Searle & Co | Immunological materials |
| US4867973A (en) * | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
| US5162512A (en) * | 1982-03-09 | 1992-11-10 | Cytogen Corporation | Amine derivatives of anthracycline antibodies |
| US4950738A (en) * | 1984-09-13 | 1990-08-21 | Cytogen Corporation | Amine derivatives of anthracycline antibiotics |
| JPS59186924A (ja) * | 1983-04-08 | 1984-10-23 | Kureha Chem Ind Co Ltd | ヒト免疫グロブリン結合抗腫瘍剤 |
| US4545985A (en) | 1984-01-26 | 1985-10-08 | The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services | Pseudomonas exotoxin conjugate immunotoxins |
| GB8413464D0 (en) * | 1984-05-25 | 1984-07-04 | Erba Farmitalia | Anthracycline-anionic polymer conjugates |
| JPS61155334A (ja) * | 1984-12-28 | 1986-07-15 | Teijin Ltd | 殺細胞性修飾免疫グロブリン及びその製造方法 |
| FR2584293B1 (fr) * | 1985-07-04 | 1989-03-17 | Ire Celltarg Sa | Anticorps utiles comme agents de pilotage et conjugues les incorporant |
-
1988
- 1988-03-10 JP JP63055074A patent/JP2736255B2/ja not_active Expired - Lifetime
- 1988-03-10 CA CA000561042A patent/CA1329156C/en not_active Expired - Lifetime
- 1988-03-10 KR KR1019880002464A patent/KR0130906B1/ko not_active IP Right Cessation
- 1988-03-10 AU AU12881/88A patent/AU622105B2/en not_active Expired
- 1988-03-10 IE IE70188A patent/IE64781B1/xx not_active IP Right Cessation
- 1988-03-10 ES ES8800719A patent/ES2006109A6/es not_active Expired
- 1988-03-10 NZ NZ223834A patent/NZ223834A/xx unknown
- 1988-03-10 BE BE8800268A patent/BE1001051A4/fr not_active IP Right Cessation
- 1988-03-10 HU HU881160A patent/HU205266B/hu unknown
- 1988-03-10 MY MYPI88000250A patent/MY103231A/en unknown
- 1988-03-10 IL IL85688A patent/IL85688A0/xx not_active IP Right Cessation
- 1988-03-10 YU YU48288A patent/YU46858B/sh unknown
- 1988-03-11 PT PT86960A patent/PT86960B/pt not_active IP Right Cessation
- 1988-03-11 GR GR880100148A patent/GR1000059B/el not_active IP Right Cessation
- 1988-03-11 FI FI881158A patent/FI98706C/fi not_active IP Right Cessation
- 1988-03-11 SE SE8800886A patent/SE503402C2/sv not_active IP Right Cessation
- 1988-03-11 CZ CS881612A patent/CZ281193B6/cs not_active IP Right Cessation
- 1988-03-11 GB GB8805865A patent/GB2203154B/en not_active Expired - Lifetime
- 1988-03-11 CH CH936/88A patent/CH678815A5/de not_active IP Right Cessation
- 1988-03-11 IT IT8819746A patent/IT8819746A0/it unknown
- 1988-03-11 DK DK198801315A patent/DK173792B1/da not_active IP Right Cessation
- 1988-03-11 FR FR888803233A patent/FR2612074B1/fr not_active Expired - Lifetime
- 1988-03-11 CN CN88101810A patent/CN1045621C/zh not_active Expired - Lifetime
- 1988-03-11 NL NL8800610A patent/NL8800610A/nl not_active IP Right Cessation
- 1988-03-11 DE DE3808166A patent/DE3808166C2/de not_active Expired - Lifetime
- 1988-03-11 NO NO881105A patent/NO178954C/no not_active IP Right Cessation
- 1988-03-11 AT AT0067488A patent/AT395375B/de not_active IP Right Cessation
-
1992
- 1992-06-15 RU SU5052164A patent/RU2106147C1/ru active
-
1995
- 1995-04-11 US US08/420,712 patent/US5798097A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI924819A (fi) | Chimaera anti-icam-i-antikroppar foer maenniskobruk, foerfaranden foer deras framstaellning samt deras anvaendning | |
| NO862641D0 (no) | Monoklonalt antistoff for et antigen tilknyttet human karsinoma tumor. | |
| ATE143052T1 (de) | Chimärisches murine-mensch-immunoglobulin, spezifisch für tumorassoziertes 17-1a antigen | |
| DK99682A (da) | Immunoanalysemetoder under anvendelse af monoklonale antistoffer | |
| DE69531290D1 (de) | Antigen-besierende heteropolymere zur behandlung von autoimmunkrankheiten mittels diesen | |
| DK167884A (da) | Immunoglobulinkonjugater | |
| GR1000059B (el) | Μεθοδος παρασκευης συζυγων ενωσεων ανοσοσφαιρινης. | |
| DE3885355D1 (de) | Monoklonale Antikörper. | |
| ATE161581T1 (de) | Monoklonale antikörper gegen humane pankreas- inselzellen | |
| DE3177276D1 (de) | Monoklonale antikoerper. | |
| DK355483D0 (da) | Monoklonale antistoffer til krydsafstemning af humant vaev | |
| FI853389L (fi) | Tumoerlaekemedel och foerfarande foer dess framstaellning. | |
| DE3884646D1 (de) | Humanes Karcinom-assoziertes Antigen und an dieses Antigen bindende Antikörper. | |
| KR890700683A (ko) | 인체 면역 결핍 바이러스에 대한 항체 검색 방법 | |
| DK69690D0 (da) | Humane anti-rh(d) monoklonale antistoffer | |
| DK717888D0 (da) | Monoklonale antistoffer | |
| NL7811447A (nl) | Eiwitconcentraat en werkwijze ter bereiding daarvan. | |
| DE3785795D1 (de) | Monoklonale anti-menschliche magenkrebs-antikoerper. | |
| DK69590D0 (da) | Humane anti-rh(d) monoklonale antistoffer | |
| DK0556320T3 (da) | Monoklonale antistoffer mod Hepatitis C-virus og fremgangsmåde til anvendelse heraf | |
| NO873488D0 (no) | Monoklonale antistoffer. | |
| ATE184315T1 (de) | Neuartiges endothelzell-molekül, das die bindung von lymphozyten im menschen vermittelt | |
| ATE73854T1 (de) | Monoklonale antikoerper. | |
| NO882162D0 (no) | Monoklonale antistoffer mot ovariekreftceller (ovb-3). | |
| ATE9845T1 (de) | Verfahren zur bestimmung von antigenen, antikoerpern und deren komplexen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Right expired |